logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
P

Peter Thuss-Patience

Berlin Institute of Health
H指数:44
被引数:9,708

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Adjuvant immunotherapy in patients with resected gastric and oesophagogastric junction cancer following preoperative chemotherapy with high risk for recurrence (ypND and/or R1): European Organisation of Research and Treatment of Cancer (EORTC) 1707 VESTIGE study

术前化疗后复发风险高的胃和食管胃交界癌患者的辅助免疫治疗 (ypND和/或R1): 欧洲癌症研究与治疗组织 (EORTC) 1707痕迹研究

ANNALS OF ONCOLOGY
IF65.4
2025-02-013
OAAI
Lordick, F.; Mauer, M. E.; Stocker, G.; Cella, C. A.; Ben-Aharon, I.; Piessen, G.; Wyrwicz, L.; Al-Haidari, G.; Fleitas-Kanonnikoff, T.; Boige, V.; Obermannova, R. Lordick; Martens, U. M.; Gomez-Martin, C.; Thuss-Patience, P.; Arrazubi, V.; Avallone, A.; Shiu, K. K.; Artru, P.; Brenner, B.; Sanchez, C. Buges; Chau, I.; Lorenzen, S.; Daum, S.; Sinn, M.; Merelli, B.; van Grieken, N. C. T.; Nilsson, M.; Collienne, M.; Giraut, A.; Smyth, E.
Modified FOLFOX plus/minus nivolumab and ipilimumab vs FLOT plus nivolumab in patients with previously untreated advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction: Final results of the IKF-AIO-Moonlight trial

改良FOLFOX联合或不联合纳武利尤单抗和伊匹木单抗对比FLOT联合纳武利尤单抗治疗既往未接受治疗的胃或胃食管结合部腺癌晚期或转移性患者的最终结果：IKF-AIO-Moonlight试验

ANNALS OF ONCOLOGY
IF65.4
2024-09-012
PRE
Lorenzen, S.; Goetze, T. O.; Thuss-Patience, P. C.; Knorrenschild, J. Riera; Goekkurt, E.; Dechow, T. N.; Ettrich, T. J.; Hofheinz, R. D.; Luley, K.; Pink, D.; Lindig, U.; Folprecht, G.; Schuch, G.; Bitzer, M.; Heinemann, V.; Angermeier, S.; Bolling, C.; Junge, S.; Pauligk, C.; Al-Batran, S-E.
Functional status and quality of life in older patients with advanced esophageal squamous cell cancer receiving second-line nivolumab ± ipilimumab therapy: A post hoc analysis of the phase 2, multicenter RAMONA study
JOURNAL OF GERIATRIC ONCOLOGY
IF2.7
2024-09-010
PRE
Li, Moying; Meindl-Beinker, Nadja M.; Maenz, Martin; Betge, Johannes; Schulte, Nadine; Zhan, Tianzuo; Hofheinz, Ralf-Dieter; Vogel, Arndt; Angermeier, Stefan; Bolling, Claus; de Wit, Maike; Jakobs, Ralf; Karthaus, Meinolf; Stocker, Gertraud; Thuss-Patience, Peter; Leidig, Tobias; Bauer, Hans; Ebert, Matthias P.; Haertel, Nicolai
Efficacy of ramucirumab combination chemotherapy as second-line treatment in patients with advanced adenocarcinoma of the stomach or gastroesophageal junction after exposure to checkpoint inhibitors and chemotherapy as first-line therapy
INTERNATIONAL JOURNAL OF CANCER
IF4.7
2024-03-066
OA
Masetti, Michael; Al-Batran, Salah-Eddin; Goetze, Thorsten O.; Thuss-Patience, Peter; Knorrenschild, Jorge Riera; Goekkurt, Eray; Folprecht, Gunnar; Ettrich, Thomas Jens; Lindig, Udo; Luley, Kim Barbara; Pink, Daniel; Dechow, Tobias; Sookthai, Disorn; Junge, Sabine; Loose, Maria; Pauligk, Claudia; Lorenzen, Sylvie
Tislelizumab versus chemotherapy as second-line treatment for European and North American patients with advanced or metastatic esophageal squamous cell carcinoma: a subgroup analysis of the randomized phase III RATIONALE-302 study

替雷利珠单抗对比化疗作为欧洲和北美晚期或转移性食管鳞状细胞癌患者二线治疗：RATIONALE-302随机化Ⅲ期研究的亚组分析

ESMO OPEN
IF8.3
2024-01-012
OAAI
Ajani, J.; El Hajbi, F.; Cunningham, D.; Alsina, M.; Thuss-Patience, P.; Scagliotti, G. V.; Van den Eynde, M.; Kim, S-b.; Kato, K.; Shen, L.; Li, L.; Ding, N.; Shi, J.; Barnes, G.; Van Cutsem, E.
German, Austrian, and Swiss guidelines for systemic treatment of gastric cancer

德国、奥地利和瑞士胃癌系统治疗指南

GASTRIC CANCER
IF5.1
2023-10-176
OAAI
Lordick, Florian; Al-Batran, Salah-Eddin; Arnold, Dirk; Borner, Markus; Bruns, Christiane J.; Eisterer, Wolfgang; Faber, Gerhard; Gockel, Ines; Koeberle, Dieter; Lorenzen, Sylvie; Moehler, Markus; Pritzkuleit, Ron; Stahl, Michael; Thuss-Patience, Peter; Woell, Ewald; Zander, Thomas; Maschmeyer, Georg
Textbook Outcome after Gastrectomy for Gastric Cancer Is Associated with Improved Overall and Disease-Free Survival

胃癌胃切除术后的教科书结果与总体和无病生存率的提高有关

JOURNAL OF CLINICAL MEDICINE
IF2.9
2023-08-216
OAAI
cetinkaya-Hosgoer, Candan; Seika, Philippa; Raakow, Jonas; Kroell, Dino; Dobrindt, Eva Maria; Maurer, Max Magnus; Martin, Friederike; Ossami Saidy, Ramin Raul; Thuss-Patience, Peter; Pratschke, Johann; Biebl, Matthias; Denecke, Christian; Weber, H. Christian
EORTC 1707 VESTIGE: Adjuvant immunotherapy in patients (pts) with resected gastroesophageal adenocarcinoma (GEA) following preoperative chemotherapy with high risk for recurrence (ypN+ and/or R1)-an open-label randomized controlled phase II study
ANNALS OF ONCOLOGY
IF65.4
2023-06-017
OAAI
Smyth, E.; Mauer, M.; Cella, C.; Ben-Aharon, I.; Piessen, G.; Wyrwicz, L.; Al-Haidari, G.; Kanonnikoff, T. Fleitas; Boige, V.; Stahl, M.; Martens, U.; Obermannova, R.; Gomez-Martin, C.; Thuss-Patience, P.; Arrazubi, V.; Avallone, A.; Shiu, K.; Collienne, M.; Giraut, A.; Lordick, F.
Integrating trastuzumab (T), with or without pertuzumab (P), into perioperative chemotherapy (CT) of HER-2+gastric cancer (GC) - subgroup analyses of EORTC 1203 INNOVATION, a collaboration with KCSG and DUCG
ANNALS OF ONCOLOGY
IF65.4
2023-06-012
OA
Wagner, A.; Grabsch, H.; Mauer, M.; Lorenzen, S.; Bouche, O.; Thuss-Patience, P.; Elme, A.; Moehler, M.; Romario, U. Fumagalli; Kang, Y.; Folprecht, G.; Martens, U.; Guzman, M. Galan; Ducreux, M.; Garcia, M. Diez; Piessen, G.; Collienne, M.; Lordick, F.
Effects of a communication training for oncologists on early addressing palliative and end-of-life care in advanced cancer care (PALLI-COM) a randomized, controlled trial

肿瘤学家沟通培训对晚期癌症治疗中早期解决姑息治疗和生命终止护理的影响 (palli-com) 一项随机对照试验

ESMO OPEN
IF8.3
2022-12-017
OAAI
Harnischfeger, N.; Rath, H. M.; Alt-Epping, B.; Brand, H.; Haller, K.; Letsch, A.; Rieder, N.; Thuss-Patience, P.; Bokemeyer, C.; Bergelt, C.; Oechsle, K.
FOLFIRI plus ramucirumab versus paclitaxel plus ramucirumab as second-line therapy for patients with advanced or metastatic gastroesophageal adenocarcinoma with or without prior docetaxel- results from the phase II RAMIRIS Study of the German Gastric Cancer Study Group at AIO

FOLFIRI联合ramucirumab与紫杉醇联合ramucirumab作为晚期或转移性胃食管腺癌患者的二线治疗，有或没有多西他赛-AIO德国胃癌研究小组II期RAMIRIS研究的结果

EUROPEAN JOURNAL OF CANCER
IF7.1
2022-04-0121
PRE
Lorenzen, Sylvie; Thuss-Patience, Peter; Pauligk, Claudia; Goekkurt, Eray; Ettrich, Thomas; Lordick, Florian; Stahl, Michael; Reichardt, Peter; Soekler, Martin; Pink, Daniel; Probst, Stefan; Hinke, Axel; Goetze, Thorsten O.; Al-Batran, Salah E.
Efficacy and safety of trifluridine/tipiracil in older and younger patients with metastatic gastric or gastroesophageal junction cancer: subgroup analysis of a randomized phase 3 study (TAGS)
GASTRIC CANCER
IF5.1
2022-01-088
OAAI
Shitara, Kohei; Doi, Toshihiko; Hosaka, Hisashi; Thuss-Patience, Peter; Santoro, Armando; Longo, Federico; Ozyilkan, Ozgur; Cicin, Irfan; Park, David; Zaanan, Aziz; Pericay, Carles; Ozguroglu, Mustafa; Alsina, Maria; Makris, Lukas; Benhadji, Karim A.; Ilson, David H.
Pazopanib with 5-FU and oxaliplatin as first line therapy in advanced gastric cancer: A randomized phase-II study-The PaFLO trial. A study of the Arbeitsgemeinschaft Internistische Onkologie AIO-STO-0510
INTERNATIONAL JOURNAL OF CANCER
IF4.7
2021-11-1514
OA
Hoegner, Anica; Al-Batran, Salah-Eddin; Siveke, Jens T.; Lorenz, Mario; Bartels, Prisca; Breithaupt, Kirstin; Malfertheiner, Peter; Homann, Nils; Stein, Alexander; Glaeser, Dietrich; Tamm, Ingo; Hinke, Axel; Vogel, Arndt; Thuss-Patience, Peter
ASO Visual Abstract: Sodium Thiosulfate Reduces Acute Kidney Injury in Patients Undergoing Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy with Cisplatin-A Single Center Observational Study
ANNALS OF SURGICAL ONCOLOGY
IF3.5
2021-09-070
PRE
Kurreck, Annika; Gronau, Felix; Alberto Vilchez, Miguel Enrique; Abels, Wiltrud; Enghard, Philipp; Brandl, Andreas; Francis, Roland; Foehre, Bettina; Lojewski, Christian; Pratschke, Johann; Thuss-Patience, Peter; Modest, Dominik; Rau, Beate; Feldbruegge, Linda

研究方向

暂未获取到该数据
S
Sylvie Lorenzen
H 指数:37论文数:379被引数:6,232
F
Florian Lordick
H 指数:91论文数:989被引数:4.8万
C
Claudia Pauligk
H 指数:34论文数:253被引数:8,503
R
Ralf‐Dieter Hofheinz
H 指数:57论文数:606被引数:1.8万
S
Salah‐Eddin Al‐Batran
H 指数:53论文数:366被引数:1.7万
D
Daniel Pink
H 指数:33论文数:238被引数:8,611
T
Thomas J. Ettrich
H 指数:35论文数:300被引数:4,643
J
Johann Pratschke
H 指数:70论文数:1,200被引数:2.2万
J
Jorge Riera Knorrenschild
H 指数:14论文数:91被引数:1,271
E
Eric Van Cutsem
H 指数:174论文数:1,832被引数:17.5万